Dr. Rakesh Mishra, Director, Tata Institute for Genetics and Society, India speaks to The Hindu on the COVID-19 pandemic, vaccines, variants and steps we need to take in order to ensure maximum safety, without hampering the economy.
Related Posts
TIGS and CSIR – North East Institute Of Science And Technology (NEIST) ink MoU
In the face of climate change, research on plant disease diagnostics, AMR... read more
MoU signing with DBT – National Institute for Animal Biotechnology
TIGS and DBT - National Institute of Animal Biotechnology (NIAB), Hyderabad got... read more
An Uphill Battle
Dr. Vasanth Thamodaran, Senior Scientist at TIGS was featured in an article... read more
REDRESS 2025: A Two-Day Convergence on Rare Genetic Diseases
Click for REDRESS 2025 Meeting Proceedings The 4th Rare Genetic Diseases Research Summit... read more
PhD Admissions – List of shortlisted candidates
List of shortlisted candidates for TIGS PhD admissions (Jan 2023) via AcSIR... read more
TIGS and inStem join hands to work on rare genetic diseases
Scientific breakthroughs from the last few decades have now made it possible... read more
Healthcare to agriculture: How genome revolution could be game changer
Dr. Rakesh Mishra, Director at TIGS, and Dr. Saveetha Meganathan, Research Scientist at... read more
Talk by Dr. Rakesh Mishra at Rare Diseases Summit 2023
Dr Rakesh Mishra, Director, Tata Institute for Genetics and Society, was invited... read more
Interview with Dr.Rakesh Mishra on IndiaScience TV
How dangerous is the new XE variant of Covid-19? Is the Covid... read more
SAGE 2026 participants visit to TIGS
We recently hosted the participants of the Sustainability Ambassadors Global Exchange (SAGE)... read more